$NVO (+0,66%) | via http://overnightstocks.com
• Novo Nordisk has reduced its 2025 sales and operating profit forecast.
• Updated guidance details were not disclosed in the initial GNW note.
• The revision follows adjustments in market dynamics and product expectations.